TENIDAP ENHANCES P2Z P2X(7) RECEPTOR SIGNALING IN MACROPHAGES/

Citation
Jm. Sanz et al., TENIDAP ENHANCES P2Z P2X(7) RECEPTOR SIGNALING IN MACROPHAGES/, European journal of pharmacology, 355(2-3), 1998, pp. 235-244
Citations number
30
Categorie Soggetti
Pharmacology & Pharmacy
ISSN journal
00142999
Volume
355
Issue
2-3
Year of publication
1998
Pages
235 - 244
Database
ISI
SICI code
0014-2999(1998)355:2-3<235:TEPPRS>2.0.ZU;2-W
Abstract
Tenidap is an anti-inflammatory drug whose mechanism of action is not fully understood. It has been shown to block plasma membrane anion tra nsport and to decrease release of interleukin-1 beta, probably via the inhibition of interleukin-1 beta converting enzyme. In the present st udy we showed that: (a) tenidap increases the sensitivity of mouse mac rophages to cytotoxic effects mediated by extracellular ATP; (b) tenid ap increases lucifer yellow uptake through the macrophage ATP receptor ; (c) pretreatment with oxidised ATP, a blocker of the P2Z/P2X(7) rece ptor, inhibits cytotoxicity and lucifer yellow uptake due to the combi ned effects of ATP and tenidap; (d) macrophages lacking the P2Z/P2X(7) receptor are resistant to the synergistic effect of tenidap and ATP. The results suggest that tenidap synergises with extracellular ATP for activation of the P2Z/P2X(7) receptor. (C) 1998 Elsevier Science B.V. All rights reserved.